CO4700376A1 - METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED - Google Patents

METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED

Info

Publication number
CO4700376A1
CO4700376A1 CO96030451A CO96030451A CO4700376A1 CO 4700376 A1 CO4700376 A1 CO 4700376A1 CO 96030451 A CO96030451 A CO 96030451A CO 96030451 A CO96030451 A CO 96030451A CO 4700376 A1 CO4700376 A1 CO 4700376A1
Authority
CO
Colombia
Prior art keywords
formula
prevention
manufacturing
produced
methods
Prior art date
Application number
CO96030451A
Other languages
Spanish (es)
Inventor
Erika Isolauri
Leena Metsaniity
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaoja
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Oy filed Critical Valio Oy
Priority to CO96030451A priority Critical patent/CO4700376A1/en
Publication of CO4700376A1 publication Critical patent/CO4700376A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para preparar una fórmula de hidrolizado de proteínaspara disminuir las recciones de hipersesibilidad y para promover una barrera inmunitaria en el intestino, que comprende los pasos de: hidrolizar proteínas con enzimas derivadas de una preparación bacteriana que comprende bacterias gastrointestinales probióticas, especialmente lactobacilos, que tienen características de adherencia y de colonización y un sistema de enzima proteasa que son similares a los de la cepa Lactobacillus GG (ATCC 53103), y con pepsina y/o tripsina. Un método para preparar una fórmula de hidrolizado de proteínas para disminuir las reacciones de hipersensibilidad y para promover una barrera inmunitaria en el intestino, que comprende los pasos de: hidrolizar proteínas con pepsina y/o tripsina, y agregar al hidrolizado una preparación bacteriana que comprende bacterias gastrointestinales probióticas, especialmente lactobacilos, que tienen características de adherencia y de colonización y un sistema de enzima proteasa que son similares a los de la cepa Lactobacillus GG (ATCC 53103).A method of preparing a protein hydrolyzate formula to decrease hypersensitivity rections and to promote an immune barrier in the intestine, comprising the steps of: hydrolyzing proteins with enzymes derived from a bacterial preparation comprising probiotic gastrointestinal bacteria, especially lactobacilli, which they have adherence and colonization characteristics and a protease enzyme system that are similar to those of the Lactobacillus GG strain (ATCC 53103), and with pepsin and / or trypsin. A method of preparing a protein hydrolyzate formula to decrease hypersensitivity reactions and to promote an immune barrier in the intestine, comprising the steps of: hydrolyzing proteins with pepsin and / or trypsin, and adding to the hydrolyzate a bacterial preparation comprising Probiotic gastrointestinal bacteria, especially lactobacilli, which have adherence and colonization characteristics and a protease enzyme system that are similar to those of the Lactobacillus GG strain (ATCC 53103).

CO96030451A 1996-06-12 1996-06-12 METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED CO4700376A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO96030451A CO4700376A1 (en) 1996-06-12 1996-06-12 METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO96030451A CO4700376A1 (en) 1996-06-12 1996-06-12 METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED

Publications (1)

Publication Number Publication Date
CO4700376A1 true CO4700376A1 (en) 1998-12-29

Family

ID=40930058

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96030451A CO4700376A1 (en) 1996-06-12 1996-06-12 METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED

Country Status (1)

Country Link
CO (1) CO4700376A1 (en)

Similar Documents

Publication Publication Date Title
NZ310478A (en) method of making a protein hydrolysate formulation derived by hydrolysing proteins with enzymes from a probiotic gastointestinal bacteria and with pepsin and/or trypsin
Matar et al. The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion
Minervini et al. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species
Haque et al. Biofunctional properties of bioactive peptides of milk origin
WO2002083879A3 (en) Immunotherapy based on dendritic cells
WO2002102347A3 (en) Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained
JP6748099B2 (en) Milk-based protein hydrolyzate and compositions made therefrom
TR200101699T2 (en) Oral lactobacilli application for the prevention and treatment of urogenital infections
DE69839993D1 (en) PROBIOTIC MILKY ACID BACTERIUM FOR THE TREATMENT OF BACTERIAL INFECTIONS ASSOCIATED WITH SIDS
BR9808520A (en) Lactobacillus vaginal medication
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
CN101959524B (en) Anti-allergic agent
CA2567582A1 (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
DE69831420D1 (en) PREPARATION OF FOODS BY FERMENTATION OF SOJAMILCH WITH STREPTOCOCCUS THERMOPHILUS
NO975136L (en) A pharmaceutical composition comprising Lactobacillus plantarum and arginine
WO2003051345A3 (en) Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans
Kashyap et al. Identification of antibacterial and immunomodulatory bioactive peptides generated from buffalo (Bubalus bubalis) colostrum whey fermented by Lactobacillus rhamnosus C25: LC-MS/MS-based analysis
US20080292750A1 (en) Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained
Cherno et al. Immunological properties of the bacterial origin compounds
IE832055L (en) Production of antibodies.
MXPA04000869A (en) Nutritional composition preventing bacterial overgrowth.
Biziulevičius Where do the immunostimulatory effects of oral proteolytic enzymes (‘systemic enzyme therapy’) come from? Microbial proteolysis as a possible starting point
CO4700376A1 (en) METHOD FOR MANUFACTURING A PROTEIN HYDROLYSIS FORMULA, THE FORMULA ASI PRODUCED AND THE METHODS OF PREVENTION AND TREATMENT INVOLVED
DK0858501T3 (en) Lactic acid bacterial preparations and their use in the manufacture of cholesterol-lowering products
Wang et al. Two potential probiotic bacillus with proteolytic activity to dietary protein from adult feces